UNSPSC 51413901: Pitenodil

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZIB93J9J6L. European Medicines Agency schedules Pitenodil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09945MIG. Pitenodil generally arises in the molecular formula C17H27N3O3S.

UNSPSC 51413901 Pitenodil is a Commodity code representing pharmaceutical products purchased by state and local government entities for emergency medical services, health agency programs, and cooperative purchasing arrangements. State and local governments buy emergency life support medications, generic pharmaceuticals, and over-the-counter products under this code, procured primarily through sealed competitive bids and requests for proposal targeting direct-to-manufacturer and wholesaler supply channels. Issuing bodies include city fire departments (Tampa Fire Rescue in Hillsborough County), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances administering shared contracts across state and local participating members (Minnesota Multistate Cooperative Purchasing Alliance). The code reflects procurement spanning single-jurisdiction emergency medical supply replenishment and statewide or multistate framework agreements establishing pricing and supply relationships with pharmaceutical manufacturers and authorized wholesalers for broader distribution networks.

Recent activity spans Florida, Texas, Minnesota, and Oregon. The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications (Labetalol, Epinephrine, Adenosine, and Diltiazem) with a firm-price requirement, ten-day delivery, nine-month minimum shelf life, a one-year contract term with two optional renewals, and a $40,000 estimated value; the solicitation carried a 5 percent SLBE bid discount with a cap of $10,000 and required OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. The Texas HHS Commission issued RFI HHS0017013 in March 2026 exploring direct-to-manufacturer prescription programs and vendor capabilities for self-insured health plans operating outside traditional pharmacy benefit manager arrangements. The Minnesota Department of Administration, administering the MMCAP cooperative purchasing alliance, issued an RFP (S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers (Cencora, Cardinal Health, Morris & Dickson), effective July 1, 2026 with a two-year term; the RFP weighted price competitiveness at 75 percent and required cGMP certification, DSCSA compliance, and minimum commercial general liability coverage of $5,000,000.